Product image of Mycostatin (Nystatin) supplied by GNH India

Mycostatin

Active Ingredient:
Nystatin
Origin:
EU

Mycostatin (Nystatin)

Nystatin, the active ingredient in Mycostatin, is a polyene antifungal presented as an oral formulation for oral use. It treats oral and gastrointestinal candidiasis in patients who require antifungal therapy.

GNH India supplies Mycostatin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Substipharm

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mycostatin is a polyene antifungal used to manage fungal infections of the oral cavity and gastrointestinal tract.

  • Oral candidiasis (thrush): reduces fungal load and resolves symptoms such as white plaques and discomfort.
  • Gastrointestinal candidiasis: eradicates Candida overgrowth in the digestive system, relieving abdominal pain and diarrhea.
  • Prophylaxis in patients on broad‑spectrum antibiotics: helps prevent secondary Candida infection by maintaining fungal balance.

How It Works

  • Nystatin binds selectively to ergosterol, a key sterol component of fungal cell membranes. This binding creates pores that increase membrane permeability, leading to leakage of intracellular contents and ultimately fungal cell death. Because human cell membranes contain cholesterol rather than ergosterol, Nystatin exhibits selective toxicity toward fungal organisms.

Side Effects

Nystatin is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Vomiting: occasional episodes after ingestion.
  • Diarrhea: loose stools during treatment.
  • Abdominal cramps: discomfort in the lower abdomen.
  • Altered taste: temporary metallic or bitter sensation.
  • Mild skin rash: localized erythema at the mouth.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction with difficulty breathing.
  • Stevens‑Johnson syndrome: rare severe skin eruption.
  • Hepatic dysfunction: signs of liver injury such as jaundice.
  • Severe gastrointestinal upset: persistent vomiting or bloody stools.
  • Nephrotoxicity: rare kidney impairment when used with other nephrotoxic agents.
  • Hematologic abnormalities: uncommon drops in white blood cell counts.

Precautions & Warnings

Before prescribing Mycostatin, consider the following safety measures.

  • Assess renal function: adjust use in patients with severe renal impairment.
  • Monitor for hypersensitivity: discontinue if signs of allergic reaction appear.
  • Use cautiously in premature infants: limited safety data are available.
  • Avoid in patients with known hypersensitivity to polyene antifungals.
  • Review concomitant antibiotic therapy: broad‑spectrum antibiotics may alter efficacy.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Nystatin may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid)

  • Concurrent systemic amphotericin B: increased risk of nephrotoxicity.
  • High‑dose oral corticosteroids: may diminish antifungal effectiveness.

Moderate Interactions (Monitor Closely)

  • Broad‑spectrum antibiotics: may disrupt gut flora and affect Candida colonisation.
  • Antacids containing aluminum or magnesium: could affect dissolution of oral suspension.
  • Oral probiotics: may compete with Nystatin activity, requiring monitoring of therapeutic response.

Frequently Asked Questions

Mycostatin contains Nystatin, which is indicated for the treatment of oral candidiasis (thrush) and gastrointestinal candidiasis. It helps eliminate Candida species from the mouth, esophagus, and digestive tract, relieving symptoms such as white plaques, soreness, abdominal pain, and diarrhea.

Nystatin binds to ergosterol, a sterol unique to fungal cell membranes. This binding creates pores that increase membrane permeability, causing essential intracellular components to leak out, which leads to fungal cell death while sparing human cells that contain cholesterol instead of ergosterol.

The dosage of Mycostatin is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of infection, and clinical response. The prescriber will provide specific instructions on the amount and frequency of administration.

Safety data for Nystatin in pregnancy and lactation are limited. It is generally considered low risk because it is poorly absorbed from the gastrointestinal tract, but the decision to use Mycostatin should be made by a qualified healthcare provider after evaluating potential benefits and risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Mycostatin (Nystatin) is a polyene antifungal that acts locally in the gastrointestinal tract and oral cavity, unlike systemic azoles such as fluconazole which are absorbed and treat deeper infections. Nystatin’s limited absorption reduces systemic side effects, making it suitable for superficial Candida infections.

Mycostatin should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and extreme temperatures to maintain its stability and potency throughout its shelf life.

Mycostatin is taken orally as directed by the prescriber, usually in the form of a suspension or tablet that is swallowed with water. For oral thrush, the suspension may be swished in the mouth before swallowing to maximize contact with the affected area.

The most serious risks include severe allergic reactions such as anaphylaxis, rare skin conditions like Stevens‑Johnson syndrome, and potential hepatic or renal impairment when used with other nephrotoxic drugs. Patients should seek immediate medical attention if they experience difficulty breathing, rash, or jaundice.

Mycostatin should not be used by individuals with a known hypersensitivity to Nystatin or other polyene antifungals. Caution is also advised for premature infants and patients with severe renal impairment, and it should be avoided in those who have experienced serious allergic reactions to similar medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.